| PCa | prostate cancer |
| PSA | prostate-specific antigen |
| RP | radical prostatectomy |
| RT | radiation therapy |
| ECM | extracellular matrix |
| CDH1 | E-cadherin |
| EMT | epithelial to mesenchymal transition |
| lncRNAs | long non-coding RNAs |
| ER | estrogen receptor |
| eNOS | endothelial nitric oxide synthase |
| HIFs | hypoxia inducible factors |
| HOTS | H19 Opposite Tumor Suppressor |
| E2 | 17β-estradiol |
| HYP | hypoxia |
| CoCl2 | cobalt chloride |
| qPCR | quantitative polymerase chain reaction |
| KDR | vascular endothelial growth factor receptor 2 |
| EPO | erythropoietin |
| ChIP | chromatin immunoprecipitation |
| TSS | transcriptional start site |
| HDAC | histone deacetylases |
| VHL | von Hippel-Lindau tumor suppressor |
| Ca2+ | calcium |
| ITGB3 | β3 integrin subunit |
| ITGB4 | β4 integrin subunit |
| ITGA2 | α2 integrin subunit |
| RUNX2 | Runt-related transcription factor 2 |
| H3K27me3 | trimethylated lysine 27 of histone H3 |
| OSCs | organotypic slice cultures |
| CCND1 | Cyclin D1 |
| RNA-ChIP | RNA chromatin immunoprecipitation |
| DMSO | dimethyl sulfoxide |
| EDTA | ethylenediaminetetraacetic acid |
| PBS | phosphate-buffered saline |